DLBCL Interim Response Evaluation for Customised Therapy

Clinical trial NCT04226937 · UNKNOWN

Trial details

NCT number: NCT04226937
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Status: UNKNOWN
Study type: OBSERVATIONAL

High-grade B-cell Lymphoma

Start date: 2020-09-17
Primary completion: 2025-09-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.